Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [709]

Chemoradiotherapy plus induction or consolidation chemotherapy as total...

Prof Ralf-Dieter Hofheinz - Uniklinik Mannheim, Mannheim, Germany

Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer ( Prof Ralf-Dieter Hofheinz - Uniklinik Mannheim, Mannheim, Germany )

CAPTEM vs FOLFIRI as second-line treatment for mCRC patients

Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation...

CAPTEM vs FOLFIRI as second-line treatment for mCRC patients ( Dr Filippo Pietrantonio - ‎IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy )

VOLTAGE: Use of nivolumab monotherapy and radical surgery in patients with...

Dr Takayuki Yoshino - National Cancer Center Hospital East in Chiba, Japan

VOLTAGE: Use of nivolumab monotherapy and radical surgery in patients with locally advanced rectal cancer ( Dr Takayuki Yoshino - National Cancer Center Hospital East in Chiba, Japan )

TRIBE2: Latest data for patients with mCRC

Dr Chiara Cremolini - Università di Pisa, Pisa, Italy

TRIBE2: Latest data for patients with mCRC ( Dr Chiara Cremolini - Università di Pisa, Pisa, Italy )

Entrectinib in NTRK-fusion positive gastrointestinal cancers

Prof Salvatore Siena - Università degli Studi di Milano Statale, Milan, Italy

Entrectinib in NTRK-fusion positive gastrointestinal cancers ( Prof Salvatore Siena - Università degli Studi di Milano Statale, Milan, Italy )

Implementing national cancer control plans

Dr Eduardo Cazap and Dr Lisa Stevens

Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )

Comment: POLO III trial for metastatic pancreatic cancer

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Comment: POLO III trial for metastatic pancreatic cancer ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

Comment: Chemotherapy for frail and elderly patients with advanced...

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Comment: Chemotherapy for frail and elderly patients with advanced gastroesophageal cancer ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

Comment: Laparoscopic versus open resection for colorectal liver metastases

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Comment: Laparoscopic versus open resection for colorectal liver metastases ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

CheckMate-142: Updated data from MSI high metastatic colon cancer patients

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

CheckMate-142: Updated data from MSI high metastatic colon cancer patients ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

VOLFI trial final results: mFOLFOXIRI and panitumumab versus FOLFOXIRI in ECOG...

Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany

VOLFI trial final results: mFOLFOXIRI and panitumumab versus FOLFOXIRI in ECOG 0-1 and primarily non-resectable mCRC patients ( Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany )

Highlights from ASCO 2019

Asst. Prof Bishal Gyawali and Monique Biryiana

Highlights from ASCO 2019 ( Asst. Prof Bishal Gyawali and Monique Biryiana )

More from ecancer